Shanghai Haohai Biological Technology Co., Ltd. (FRA:5HB)

Germany · Delayed Price · Currency is EUR

1.740

+0.030 (1.75%)

Last updated: Oct 23, 2026, 5:15 PM CEST

Market Cap	818.73M -35.1%
Revenue (ttm)	294.84M -10.7%
Net Income	14.34M -71.6%
EPS	0.06 -71.3%
Shares Out	n/a
PE Ratio	27.52
Forward PE	n/a
Dividend	0.11 (6.17%)
Ex-Dividend Date	Sep 4, 2026

Volume	900
Open	1.730
Previous Close	1.710
Day's Range	1.730 - 1.740
52-Week Range	1.650 - 3.160
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2026

About FRA:5HB

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2007

Employees 1,999

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 5HB

Financial Performance

In 2025, FRA:5HB's revenue was 2.45 billion, a decrease of -8.71% compared to the previous year's 2.68 billion. Earnings were 251.01 million, a decrease of -40.30%.

Financial numbers in CNY Financial Statements